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lation betwe,m lipopmtaln(a) (Lp(a)) concentrations and the development of 
restenosis post PTCA, the relationship between Lp(a) and restenosis remains 
controversial. 
Method: To evaluate the predictive value of I-p(a) for restenosis we mea- 
sured Lp(a) concentrations of patients undergoing PTCA and enrolled in 
prospective restenosis trials at the Montreal Heart Institute. Between March 
1991 and September 1992, 134 patients (107 men) had full lipid profiles 
including Lp(e) level measurements. The mean age of our study popcletior, 
was 54.6 4- 8.7, 28% had a previous MI, 25% were smokers, 16% were dia- 
betic and 66% had hyperohott:sterolemia. All patients had follow up coronary 
angiography at 6 months. Sevedty of the lesions after PTCA and at follow-up 
was assessed by quantitative coronary angingraphy. Restenosis was de- 
fined as reocclusion of > 50% of a previous PTCA site. Lp(a) concentrations 
were measured by monoclc~al/polyclonal s ndwich enzyme immunoassay 
performed on fresh serum samples. 
Results: Restsnosis occurred in 47 patients (35%). Mean Lp(a) values for 
the restenosis group was 0.53 -i- 0.56 g/L For the no restenosis group (N = 
86) mean Lp(a) values was 0.57 -4- 0.68 g/I. Univadate and logistic regression 
analysis howed no correlation with any lipids including Lp(a). 
Conclusion: Our data does not support he theory of a correlation between 
serum I.p(a) concentrations and the incidence of restenosis. A prospective 
angiographic trial comp~dng patients with high Lp(a) with that of low levels 
is still required. 
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Jean-Marc Lablanche, Michel Bertrand, Philippe AmouyeL CHRU de Lille 
and Institut Pasteur de Lille 
Recebltly, the Insartion/Detetion (I/D) polymorphism of the angiotonsincon- 
vetting enzyme (ACE) gene andtheA/C 11ss polymorphism of the angiotensin- 
II type 1 receptor (AGTr R) gene have been demonstrated to have a.synergis- 
tic effect on the occurence of myocardial infarction. We studied the possible 
influence of these two genetic dsk factors on the occurrence of restenosis in 
271 consecutive patients, who underwent successful single lesion coronary 
angioplssty with systematic angiographic follow-up. The ganotype distribu- 
tions in the whole sample were 34%, 50% and 16% for DD, ID and It, 
respectively, and 11%, 38% and 51% for CC, AC and AA respectively. These 
genotype frequencies were compatible with the Hardy-Weinberg hypothesis. 
The results of quantitative coronary angiography did not show any signiff- 
c~'~t differences in reference diameter and minimal lumen diameter (MLD) of 
stenosis before aogioplasty. Immediately after PTCA, the MLD and the acute 
gain ware similar among groups of genotypes. At follow-up anglography, the 
MLD, the late loss and the net gain were not different according to genotypas. 
Finally, 4 combinations of genotypes ware defined as a dominant effect of the 
ACE D allele and a codominant effect of the AGTr R C allele. No synergistic 
effect ceutd be detected on the occurrence of restenosis. In Conclusion, 
this quantitative study did not reveal any effect of either palymorphism on 
restenosls alone or in o)mbination. 
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Man-Hoa tam, Martin Bouchard, R~mi Marfal, Angelica Flesar, 
Guy Leclero. Notre-Dame Hospital, Montr6al, Qu~.bec, Canada 
Growth factor release from damaged cells following injury could be a key 
Initiator of vascular smooth muscle coils proliferation which could eventually 
lead to restsnosis. The purpose of this study was to assess and compare the 
circulating serum levels of basic Rbroblast Growth Factor (bFGF), Vascular 
Endothelial Growth Factor (VEGF), and Transforming Growth Factor-beta 
(TGF-,81) in 25 patients undergoing parcutaneous transluminal coronary an- 
gioplasty (PTCA). Blood samples were prospectively collected immediately 
pie, post, 24, and 48 hours post procedure and growth factor levels were 
assessed immunologically using monoclosal antibodies by ELISA testing. 
A significant increase of bFGF level was observed immediately post-PTCA 
as compared to the level measured pre-pmcedure (15.1 ± f,9 pg/ml vs 9.7 
:E 1.7 pg/ml, P = 0.039). At 24 h and 48 h post-PTCA the level of bFGF 
fell respectively to 3,3 4- 0.5 pg/ml and 2.9 4- 0,5 pg/ml, which represent 
a significant decrease as compared to the level reached immediately post 
angioplasty (P = 0.0001 at beth times). VEGF levels showed significant de- 
crease immediately following the angioplesty (172 ± 31.7 pg/mt (pre) vs 34.9 
2.8 pg/ml (post) P = 0.0001). However, at 24 h post-PTCA, the levels of 
VEGF reached 277 4- 70.9 Wml (P = 0.0013 as compared to post) and 
remained elevated at that level at 48 h (254 ~ 46.3 pg/ml). We observed no 
slgnifl~nt vadatlons in the levels of TGF-/H measured at the different times. 
Conclusions: Cimulating serum levels of both bFGF and VEGF are signifi- 
santiy modified post-PTCA in human, with a rapid but short-lived increase 
with bFGF and a late and sustained increase with VEGR 
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It is well recognized that in patients (pts) with unstable angina (UP,) coronary 
angioplasty (PTCA) is hampered by an higher rate of acute complications 
and restenosis. The activation of the inflammatory system observed in UA 
may increase the dsk of complications following PTCA, because of the vaso- 
constdctive and pmcoagulant effects of cytokines. To test this hypothesis, we 
measured serum levels of C-reactive protein (a pmtotypic marker of inflam- 
maton, produced by the hepatic ells mainly after intedeukin-6 stimulation) 
in 36 pts with UA, pdor to single-vessel PTCA. Results: Elevated serum 
levels of CRP (> 3 rag/I) were found in 28/36 (78%) pts: median 15.6 mg/1, 
range 3.2-200 mg/I. Ten of the 28 UA pts (36°/=) with high levels of CRP 
had acute complications: 9 pts had o".'.'.'.'.'.'.'.'~J u sic n dudng the procedure (requidng 
stent application in 2 10ts, immediate coronary bypass surgery in 3 pts and 
thmmbelysis in 4 pts); 1 10t developed an acute myocardial infarction within 
24 hours. Furthermore, 12 of the 18 lOtS (67%) with elevated serum levels of 
CRP and no acute complications had recurrence of class IlIB (Braunwaid) 
UA, with angiographic evidence of restenosis, within 6 months. Conversely, 
none of the 8 pts with a normal value of CRP had acute complications 
and only 2 (25%) had restenosis within 6 months, with a stable pattern of 
symptoms (p = 0.015 vs UA pts with elevated levels of CRP), Moreover, a 
multivadato analysis confirmed that serum level of CRP prior to PTCA was a 
strong predictor of acute complications (tO = 0.021) and restenosis (p = 0.018) 
~iter PTCA, independent of clinical, angiographic and procedural variables. 
Conclusions: Our data demonstrate that elevated levels of CRP are pre- 
dictive of high dsk of acute cemptication and raised rate of restenosis with 
an unstable clinical presentation, inpatients with unstable angina submitted 
to PTCA, possibly because of enhanced cytokines production. 
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11013-1161 Compensation for Systolic-Diastolic Variation in 
Intracoronary Ultrasound Image Acquisition 
Mark Appleby, Andrew Deaner, Martin Rothman. Royal London Hospital, 
London E1 1BB 
Measudog intranoronary ultrasound (ICUS) images in systole (S) and diastole 
(D) at the same position in a vessel is necessary in studies of wall motion 
and vessel compliance. Longitudinal ICUS catheter moton dudng the cardiac 
cycle means different sections of vessel are imaged uring S and D, The aim 
of this study was to quantify this motion to enable compensation. 
Methods: 19 patients underwent ICUS imaging using Boston Sciantif'¢ 30 
MHz 3.5 F catheters and a Hewiett Packard Sonos 100 ¢ system following 
coronary stunt insertion. Withdrawals were performed using a microproces- 
sor controlled pull-back dev'ce gated to the R-were and moving 0.1 mm or 
0.2 mm per R-R intentaL Digitized v'~eo-frar~,as were ntagnitied and anal- 
ysed on a Power PC using NIH image ® linked to an EXCEL ® spreadsheet. 
The veesal-stent interfaces were used to allow matching of images. The lon- 
gitudinal distance between matched images were calculated and the impact 
on area measurements assessed. 
Results: 
Mean SD 
Inner Luminal Area (ILA) 7.07 rmn 2 1.82 mm ~ 
Media Bounded Area (MBA 14.3 mm 2 1.53 mm ~" 
Longitudinal separation ofmatching sys-di frames 0.24 mm 2 0.15 mm 2 
ILA sys-dl vafiaticn (same position-- uncompensated) 0.67 mm 2 0.056 mm z
MBA sys-dl variation (same position-- uncompensated) 0.57 mm 2 0.035 m~v ?- 
ILA sys-di variation (compensated) 0.41 mm 2 0.040 mrn 2
MBA Syst-Diasl vadalicn (compensated) 0.37 mm 2 0.031 mm 2 
Sys - Systolic; DI - Diastolic 
Conclusions: Beat to beat tongifudinal catheter motion of 0.1-0.4 mm sig- 
